Giacomo Cafaro Selected Research

Giacomo Cafaro Research Topics

6	COVID-19 01/2023 - 01/2020
3	Atherosclerosis 12/2023 - 01/2018
3	Rheumatoid Arthritis 10/2022 - 01/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2021
2	Infections 01/2023 - 01/2021
2	Rheumatic Diseases (Rheumatism) 01/2023 - 01/2018
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2023
1	Hypertension (High Blood Pressure) 11/2021
1	Critical Illness (Critically Ill) 01/2021
1	Cryoglobulinemia 01/2021
1	Purpura 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Leukopenia 01/2021
1	Pathologic Processes 01/2021
1	Lymphoma (Lymphomas) 07/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2020
1	Thrombosis (Thrombus) 07/2020
1	Macrophage Activation Syndrome 01/2020
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2020
1	Iron Overload 01/2020
1	Adult-Onset Still's Disease 01/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Hyperferritinemia 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Osteoarthritis 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Neoplasms (Cancer) 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015
1	Rare Diseases (Rare Disease) 12/2014
1	Muscular Diseases (Myopathy) 12/2014
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2014

2	C-Reactive ProteinIBA 10/2022 - 11/2021
2	Interleukin-6 (Interleukin 6)IBA 05/2020 - 01/2020
2	CytokinesIBA 01/2020 - 01/2019
2	InterleukinsIBA 01/2020 - 01/2019
1	LipidsIBA 12/2023
1	Colchicine FDA LinkGeneric 01/2023
1	AutoantibodiesIBA 01/2023
1	Glutens (Glutelin)IBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 10/2022
1	LDL CholesterolIBA 11/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021
1	GlobulinsIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Janus KinasesIBA 01/2021
1	AntibodiesIBA 07/2020
1	Immunoglobulin A (IgA)IBA 07/2020
1	Immunoglobulin G (IgG)IBA 07/2020
1	Immunoglobulin M (IgM)IBA 07/2020
1	Rheumatoid FactorIBA 07/2020
1	Antiphospholipid AntibodiesIBA 07/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	IronIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Immunomodulating AgentsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	AlarminsIBA 01/2019
1	ElementsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Insulin-Like Growth Factor Binding Protein 6IBA 01/2017
1	Chemotactic FactorsIBA 01/2017
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2017
1	Insulin-Like PeptidesIBA 01/2017
1	Ustekinumab (CNTO 1275)FDA Link 01/2015